The State of IndependentDermatology 2026

An original survey of 156 dermatology practice owner-operators on financial visibility, private equity, workforce strain, and the AI in their exam rooms. A read on the business from the one seat that carries the risk: the owner's.

Dermatology doesn't have oneproblem. It has several, and they'reall arriving at once.

ask the data

anything

The four pressures, together

The four pressures rarely arrive one at a time; they land together, same desk, same week. Return to the spine - each rewards the owner who can see clearly and act early. End encouraging: operational execution is the part owners control.

About the research

The State of Independent Dermatology 2026 draws on a national survey of 156 U.S. dermatologists who hold an ownership or equity stake in their practice — 80% independent, 20% private-equity-backed, so the two groups can be read against each other throughout. Respondents range from solo practitioners to multi-provider groups across urban, suburban, and rural markets. The instrument ran to roughly 25 questions and was fielded by the independent research firm PureSpectrum for Clarity RCM in March 2026. The PE-backed base (n=31) is small, so contrasts by ownership are directional rather than conclusive.

  1. American Medical Association, Physician Practice Benchmark Survey
  2. HHS OIG, Improper Payments for Evaluation and Management Services
  3. Practical Dermatology, Preparing for Private Equity
  4. JAMA Health Forum, Sale of Private Equity-Owned Physician Practices and Physician Turnover
  5. American Medical Association, Augmented Intelligence in Medicine

Clarity RCM is the only revenue cycle management company built exclusively for dermatology. Serving 200+ independent practices across 42 states, Clarity pairs billing, coding, and compliance expertise with high-touch service and a technology-driven approach. Founded in 2017, it has been ranked among America's fastest-growing private companies by Inc. three years running.